Found: 6 articles

Article Edition
G.A. Dashyan, E.S. Dzhelialov, V.V. Konstantinova, Yu.A. Gronskaya, A.D. Murskikh, R.M. Akhmedov, A.E. Tyusenko, A.A. Olchonova, Z.V. Dyakonenko, O.A. Sereda, A.M. Belousov
Primary resistance to anti-HER2 therapy: mechanisms of development and ways to overcome
№11 / 2023
V.F. Semiglazov (1), V.V. Semiglazov (2), K.S. Nikolaev (1), A.V. Komyakhov (1), T.Yu. Semiglazova (1), R.M. Paltoev (1), R.V. Donskikh (1), A.I. Tseluyko (1), A.S. Artemyeva (1), V.O. Bashlyk (1), G.F. Miryusupova (3), G.A. Dashyan (1)
DE-ESCALATION AND ESCALATION OF TREATMENT OF PATIENTS WITH HER2-POSITIVE BREAST CANCER
№17 / 2017
L.G. Zhukova, I.P. Ganshina, V.G. Zaitsev, M.V. Stepanchenko
PLACE OF LAPATINIB IN THE THERAPY OF HER2-POSITIVE BREAST CANCER
№8 / 2016
I.P. Ganshina, E.V. Lubennikova, L.G. Zhukova
DUAL HER2 BLOCKADE - A NEW DIRECTION IN THE TREATMENT OF HER2-POSITIVE BREAST CANCER
№8 / 2014
I.V. Fray, N. I. Perevodchikova
LAPATINIB FOR THE TREATNEBT OF BREAST CANCER
№10 / 2014
T.Yu Semiglazova, L.V. Filatova, D.Kh Latipova, M.L. Gershanovich
Target Therapy Her2-positive Breast Cancer With Brain Metastases: New Prospects For Treatment
№17 / 2010


Бионика Медиа